A. S. Ahmed, M. A. Chowdhury, M. Hoque, and G. L. Darmstadt, Clinical and bacteriological profile of neonatal septicemia in a tertiary level pediatric hospital in Bangladesh, Indian Pediatr, issue.11, pp.39-1034, 2002.

A. A. Alghasham and M. C. Nahata, Clinical Use of Fluoroquinolones in Children, Annals of Pharmacotherapy, vol.15, issue.12, pp.347-59, 2000.
DOI : 10.1345/aph.18146

K. Allegaert, A. Rochette, and F. Veyckemans, Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance, Pediatric Anesthesia, vol.92, issue.9536, pp.266-73, 2011.
DOI : 10.1111/j.1460-9592.2010.03389.x

P. Amiel, D. Moreau, C. Vincent-genod, C. Alberti, R. Hankard et al., Noninvitation of Eligible Individuals to Participate in Pediatric Studies, Archives of Pediatrics & Adolescent Medicine, vol.161, issue.5, pp.161-446, 2007.
DOI : 10.1001/archpedi.161.5.446
URL : https://hal.archives-ouvertes.fr/hal-00850487

B. J. Anderson, K. Allegaert, and N. H. Holford, Population clinical pharmacology of children: general principles, European Journal of Pediatrics, vol.28, issue.11, pp.165-741, 2006.
DOI : 10.1007/s00431-006-0188-y

B. J. Anderson, K. Allegaert, and N. H. Holford, Population clinical pharmacology of children: modelling covariate effects, European Journal of Pediatrics, vol.42, issue.1, pp.165-819, 2006.
DOI : 10.1007/s00431-006-0189-x

V. M. Aquino, L. Herrera, E. S. Sandler, and G. Buchanan, Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer, Cancer, vol.88, issue.7, pp.88-1710, 2000.
DOI : 10.1002/(SICI)1097-0142(20000401)88:7<1710::AID-CNCR27>3.3.CO;2-T

B. S. Arant and . Jr, Developmental patterns of renal functional maturation compared in the human neonate, The Journal of Pediatrics, vol.92, issue.5, pp.705-717, 1978.
DOI : 10.1016/S0022-3476(78)80133-4

R. W. Armstrong, E. R. Eichner, D. E. Klein, W. F. Barthel, J. V. Bennett et al., Pentachlorophenol poisoning in a nursery for newborn infants. II. Epidemiologic and toxicologic studies, The Journal of Pediatrics, vol.75, issue.2, pp.75-317, 1969.
DOI : 10.1016/S0022-3476(69)80407-5

R. K. Arora, A. Gupta, N. M. Joshi, V. K. Kataria, P. Lall et al., Multidrug resistant typhoid fever: study of an outbreak in Calcutta, Indian Pediatr, issue.1, pp.29-61, 1992.

Y. Aujard, C. Farnoux, S. Lefevre, L. Maury, A. L. Delezoide et al., Candida infections in newborns], Arch Pediatr, issue.10 5, pp.569-574, 2003.

Y. Aujard and D. Gendrel, Les quinolones en pédiatrie, 1994.

B. Aurangzeb and A. Hameed, Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns, J Coll Physicians Surg Pak, issue.11, pp.13-629, 2003.

S. Avenel, A. Bomkratz, G. Dassieu, J. C. Janaud, and C. Danan, Incidence des prescriptions hors autorisation de mise sur le march?? en r??animation n??onatale, Archives de P??diatrie, vol.7, issue.2, pp.143-150, 2000.
DOI : 10.1016/S0929-693X(00)88083-5

M. Bajcetic, M. Jelisavcic, J. Mitrovic, N. Divac, S. Simeunovic et al., Off label and unlicensed drugs use in paediatric cardiology, European Journal of Clinical Pharmacology, vol.27, issue.10, pp.61-775, 2005.
DOI : 10.1007/s00228-005-0981-y

P. Ball and G. Tillotson, Tolerability of Fluoroquinolone Antibiotics Past, Present and Future, Drug Safety, vol.13, issue.6, pp.343-58, 1995.
DOI : 10.2165/00002018-199513060-00004

H. O. Ballard, L. A. Shook, N. S. Desai, and K. J. Anand, Neonatal Research and the Validity of Informed Consent Obtained in the Perinatal Period, Journal of Perinatology, vol.24, issue.7, pp.24-409, 2004.
DOI : 10.1038/sj.jp.7211142

J. Barr, G. Brenner-zada, E. Heiman, G. Pareth, M. Bulkowstein et al., Unlicensed and Off-Label Medication Use in a Neonatal Intensive Care Unit: A Prospective Study, American Journal of Perinatology, vol.19, issue.2, pp.67-72, 2002.
DOI : 10.1055/s-2002-23557

C. Bartlett, J. Sterne, and M. Egger, What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers, BMJ, vol.325, issue.7355, pp.325-81, 2002.
DOI : 10.1136/bmj.325.7355.81

F. C. Battaglia and L. O. Lubchenco, A practical classification of newborn infants by weight and gestational age, The Journal of Pediatrics, vol.71, issue.2, pp.71-159, 1967.
DOI : 10.1016/S0022-3476(67)80066-0

A. Bavdekar, M. Chaudhari, S. Bhave, and A. Pandit, Ciprofloxacin in typhoid fever, The Indian Journal of Pediatrics, vol.13, issue.Supplement 4A, pp.335-344, 1991.
DOI : 10.1007/BF01642807

E. Bellissant, S. Courcier-duplantier, and O. Blin, Role of pharmacokineticpharmacodynamic relationships in drug development], Therapie, vol.57, issue.4, pp.347-57, 2002.

E. Bellissant, V. Sebille, and G. Paintaud, Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling, Clinical Pharmacokinetics, vol.35, issue.2, pp.151-66, 1998.
DOI : 10.2165/00003088-199835020-00004

D. K. Benjamin, E. Delong, C. M. Cotten, H. P. Garges, W. J. Steinbach et al., Mortality Following Blood Culture in Premature Infants: Increased with Gram-negative Bacteremia and Candidemia, but Not Gram-positive Bacteremia, Journal of Perinatology, vol.24, issue.3, pp.24-175, 2004.
DOI : 10.1038/sj.jp.7211068

D. K. Benjamin, . Jr, B. J. Stoll, A. A. Fanaroff, S. A. Mcdonald et al., Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months, PEDIATRICS, vol.117, issue.1, pp.84-92, 2006.
DOI : 10.1542/peds.2004-2292

K. Benson and A. J. Hartz, A comparison of observational studies and randomized, controlled trials, N Engl J Med, issue.25, pp.342-1878, 2000.

M. J. Bizzarro and P. G. Gallagher, Antibiotic-Resistant Organisms in the Neonatal Intensive Care Unit, Seminars in Perinatology, vol.31, issue.1, pp.31-57, 2007.
DOI : 10.1053/j.semperi.2007.01.004

A. Black, A. O. Redmond, H. J. Steen, and I. Oborska, Tolerance and safety of ciprofloxacin in paediatric patients, Journal of Antimicrobial Chemotherapy, vol.26, issue.suppl F, pp.25-34, 1990.
DOI : 10.1093/jac/26.suppl_F.25

W. A. Bleyer, Re: Recruiting Minorities Into Clinical Trials: Toward a Participant-Friendly System, JNCI Journal of the National Cancer Institute, vol.88, issue.6
DOI : 10.1093/jnci/88.6.377

B. Group, British National Formulary For Children, 2009.

E. Bouza, M. D. Diaz-lopez, J. C. Bernaldo-de-quiros, and M. Rodriguez-creixems, Ciprofloxacin in patients with bacteremic infections, The American Journal of Medicine, vol.87, issue.5, pp.228-231, 1989.
DOI : 10.1016/0002-9343(89)90065-X

J. Boyle, Acid Secretion From Birth to Adulthood, Journal of Pediatric Gastroenterology and Nutrition, vol.37, issue.Supplement 1, pp.12-18, 2003.
DOI : 10.1097/00005176-200311001-00004

K. Brendel, C. Dartois, E. Comets, A. Lemenuel-diot, C. Laveille et al., Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from, Clin Pharmacokinet, issue.3, pp.46-221, 2002.
URL : https://hal.archives-ouvertes.fr/inserm-00159124

E. Burgess, N. Singhal, H. Amin, D. D. Mcmillan, and H. Devrome, Consent for clinical research in the neonatal intensive care unit: a retrospective survey and a prospective study, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.88, issue.4, pp.280-285, 2003.
DOI : 10.1136/fn.88.4.F280

P. H. Caldwell, P. N. Butow, and J. C. Craig, Pediatricians' attitudes toward randomized controlled trials involving children, The Journal of Pediatrics, vol.141, issue.6, pp.141-798, 2002.
DOI : 10.1067/mpd.2002.129173

P. H. Caldwell, P. N. Butow, and J. C. Craig, Parents' attitudes to children's participation in randomized controlled trials, The Journal of Pediatrics, vol.142, issue.5, pp.554-563, 2003.
DOI : 10.1067/mpd.2003.192

P. H. Caldwell, J. C. Craig, and P. N. Butow, Barriers to Australian physicians' and paediatricians' involvement in randomised controlled trials, Med J Aust, vol.182, issue.2, pp.59-65, 2005.

P. H. Caldwell, S. Hamilton, A. Tan, and J. Craig, Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review, PLoS Medicine, vol.2, issue.11, p.1000368, 2010.
DOI : 10.1371/journal.pmed.1000368.s001

P. H. Caldwell, S. B. Murphy, P. N. Butow, and J. Craig, Clinical trials in children, The Lancet, vol.364, issue.9436, pp.364-803, 2004.
DOI : 10.1016/S0140-6736(04)16942-0

G. D. Cappon, G. P. Bailey, J. Buschmann, M. H. Feuston, J. E. Fisher et al., Juvenile animal toxicity study designs to support pediatric drug development, Birth Defects Research Part B: Developmental and Reproductive Toxicology, vol.68, issue.6, pp.86-463, 2009.
DOI : 10.1002/bdrb.20220

R. E. Carter, Application of stochastic processes to participant recruitment in clinical trials, Controlled Clinical Trials, vol.25, issue.5, pp.429-465, 2004.
DOI : 10.1016/j.cct.2004.07.002

A. Ceci, M. Felisi, P. Baiardi, F. Bonifazi, M. Catapano et al., Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years, European Journal of Clinical Pharmacology, vol.61, issue.11, pp.62-947, 2006.
DOI : 10.1007/s00228-006-0193-0

M. Cella, F. Gorter-de-vries, D. Burger, M. Danhof, D. Pasqua et al., A Model-Based Approach to Dose Selection in Early Pediatric Development, Clinical Pharmacology & Therapeutics, vol.43, issue.3, pp.294-302, 2010.
DOI : 10.1016/j.cmpb.2003.11.003

M. Chalumeau, D. Gendrel, G. Breart, and G. Pons, An example of hospital-based pharmacoepidemiology in paediatrics: tolerance to fluoroquinolones], Arch Pediatr, issue.6, pp.11-500, 2004.

M. Chalumeau, S. Tonnelier, P. D-'athis, J. M. Treluyer, D. Gendrel et al., Fluoroquinolone Safety in Pediatric Patients: A Prospective, Multicenter, Comparative Cohort Study in France, PEDIATRICS, vol.111, issue.6, pp.714-723, 2003.
DOI : 10.1542/peds.111.6.e714

M. Chalumeau, J. M. Treluyer, B. Salanave, R. Assathiany, G. Cheron et al., Off label and unlicensed drug use among French office based paediatricians, Archives of Disease in Childhood, vol.83, issue.6, pp.83-502, 2000.
DOI : 10.1136/adc.83.6.502
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1718582

M. A. Channa and M. Z. Janjua, Effects of ciprofloxacin on foetal hepatocytes, J Pak Med Assoc, issue.10, pp.53-448, 2003.

J. S. Cheesbrough, F. I. Mwema, S. D. Green, and G. S. Tillotson, Quinolones in children with invasive salmonellosis, The Lancet, vol.338, issue.8759, pp.338-127, 1991.
DOI : 10.1016/0140-6736(91)90127-B

J. M. Chessells, C. Bailey, and S. M. Richards, Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia, Lancet, issue.8943, pp.345-143, 1995.

G. Chirico, F. Barbieri, and C. Chirico, Antibiotics for the newborn, The Journal of Maternal-Fetal & Neonatal Medicine, vol.91, issue.1, pp.46-55, 2009.
DOI : 10.1542/peds.2007-1232

I. Choonara, Clinical trials of medicines in children, BMJ, vol.321, issue.7269, pp.321-1093, 2000.
DOI : 10.1136/bmj.321.7269.1093

I. Choonara and S. Conroy, Unlicensed and Off-Label Drug Use in Children, Drug Safety, vol.82, issue.1, pp.1-5, 2002.
DOI : 10.2165/00002018-200225010-00001

D. A. Church, J. F. Kanga, R. J. Kuhn, T. T. Rubio, W. A. Spohn et al., Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations, The Pediatric Infectious Disease Journal, vol.16, issue.1, pp.97-105, 1997.
DOI : 10.1097/00006454-199701000-00031

V. Chysky, K. Kapila, R. Hullmann, G. Arcieri, P. Schacht et al., Vertr??glichkeit von Ciprofloxacin bei Kindern unter besonderer Beachtung der Gelenke. Auswertung weltweit dokumentierter Problemf??lle, Infection, vol.i, issue.Suppl. 12, pp.289-96, 1991.
DOI : 10.1007/BF01644970

R. H. Clark, B. T. Bloom, A. R. Spitzer, and D. R. Gerstmann, Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data Set, PEDIATRICS, vol.117, issue.6, pp.117-1979, 2006.
DOI : 10.1542/peds.2005-1707

G. M. Cleary, S. T. Higgins, D. A. Merton, J. A. Cullen, R. P. Gottlieb et al., Developmental changes in renal artery blood flow velocity during the first three weeks of life in preterm neonates, The Journal of Pediatrics, vol.129, issue.2, pp.129-251, 1996.
DOI : 10.1016/S0022-3476(96)70250-0

J. P. Collet, D. Floret, P. Cochat, J. Gillet, J. Cogan-collet et al., Group meetings for patient recruitment in clinical trial in pediatrics

E. Comets, K. Brendel, and F. Mentre, Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R, Computer Methods and Programs in Biomedicine, vol.90, issue.2, pp.90-154, 2008.
DOI : 10.1016/j.cmpb.2007.12.002
URL : https://hal.archives-ouvertes.fr/inserm-00274332

J. Concato, N. Shah, and R. I. Horwitz, Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs, New England Journal of Medicine, vol.342, issue.25, pp.342-1887, 2000.
DOI : 10.1056/NEJM200006223422507

S. Conroy, J. Mcintyre, and I. Choonara, Unlicensed and off label drug use in neonates ?? Commentary, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.80, issue.2, pp.142-146, 1999.
DOI : 10.1136/fn.80.2.F142

L. E. Cuevas, P. Kazembe, G. K. Mughogho, G. S. Tillotson, and C. A. Hart, Eradication Of Nasopharyngeal Carriage Of Neisseria Meningitidis In Children And Adults In Rural Africa: A Comparison Of Ciprofloxacin And Rifampicin, Journal of Infectious Diseases, vol.171, issue.3, pp.171-728, 1995.
DOI : 10.1093/infdis/171.3.728

L. Cuzzolin, A. Atzei, and V. Fanos, Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety, Expert Opinion on Drug Safety, vol.98, issue.5, pp.703-721, 2006.
DOI : 10.1136/adc.78.5.402

D. Agostino and R. B. Jr, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, pp.17-2265, 1998.

D. Agostino, R. B. Jr, D. Agostino, and R. B. Sr, Estimating Treatment Effects Using Observational Data, JAMA, vol.297, issue.3, pp.314-320, 2007.
DOI : 10.1001/jama.297.3.314

J. Dalen, R. Annette, J. Brody, and M. Perryman, Influences upon pediatricians&rsquo; willingness to refer patients to clinical research, Open Access Journal of Clinical Trials, issue.2, pp.23-28, 2010.
DOI : 10.2147/OAJCT.S8244

J. S. Daly, M. G. Worthington, S. A. Razvi, and R. Robillard, Brief report: Intravenous and sequential intravenous and oral ciprofloxacin in the treatment of severe infections, The American Journal of Medicine, vol.87, issue.5, pp.232-234, 1989.
DOI : 10.1016/0002-9343(89)90066-1

D. Cock, R. F. Piana, C. Krekels, E. H. Danhof, M. Allegaert et al., The role of population PK???PD modelling in paediatric clinical research, European Journal of Clinical Pharmacology, vol.59, issue.6, pp.5-16, 2011.
DOI : 10.1007/s00228-009-0782-9
URL : https://hal.archives-ouvertes.fr/hal-00594491

D. Schaepdrijver, L. Rouan, M. C. Raoof, A. Bailey, G. P. De-zwart et al., Real life juvenile toxicity case studies: The good, the bad and the ugly, Reproductive Toxicology, vol.26, issue.1, pp.54-59, 2008.
DOI : 10.1016/j.reprotox.2008.04.002

S. N. De-wildt, G. L. Kearns, W. C. Hop, D. J. Murry, S. M. Abdel-rahman et al., Pharmacokinetics and metabolism of intravenous midazolam in preterm infants, Clinical Pharmacology & Therapeutics, vol.70, issue.6, pp.70-525, 2001.
DOI : 10.1067/mcp.2001.120683

S. N. De-wildt, G. L. Kearns, J. S. Leeder, and J. N. Van-den-anker, Cytochrome P450 3A, Clinical Pharmacokinetics, vol.37, issue.6, pp.37-485, 1999.
DOI : 10.2165/00003088-199937060-00004

S. N. De-wildt and C. A. Knibbe, Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children, European Journal of Clinical Pharmacology, vol.14, issue.5-6, pp.65-849, 2009.
DOI : 10.1007/s00228-009-0655-2

M. Dell-'aera, A. R. Gasbarro, M. Padovano, N. Laforgia, D. Capodiferro et al., Unlicensed and off-label use of medicines at a neonatology clinic in Italy, Pharm World Sci, vol.29, issue.4, pp.361-368, 2007.

A. Dessi, C. Salemi, V. Fanos, and L. Cuzzolin, Drug treatments in a neonatal setting: focus on the off-label use in the first month of life, Pharmacy World & Science, vol.52, issue.suppl. 3, pp.32-120, 2010.
DOI : 10.1007/s11096-009-9356-2

J. Dixey, A. N. Redington, R. C. Butler, M. J. Smith, J. R. Batchelor et al., The arthropathy of cystic fibrosis., Annals of the Rheumatic Diseases, vol.47, issue.3, pp.47-218, 1988.
DOI : 10.1136/ard.47.3.218

G. L. Drusano, Pharmacokinetics and Pharmacodynamics of Antimicrobials, Clinical Infectious Diseases, vol.45, issue.Supplement 1, pp.89-95, 2007.
DOI : 10.1086/518137

W. Du, I. Warrier, V. Tutag-lehr, V. Salari, E. Ostrea et al., Changing Patterns of Drug Utilization in a Neonatal Intensive Care Population, American Journal of Perinatology, vol.23, issue.5, pp.23-279, 2006.
DOI : 10.1055/s-2006-946719

D. M. Duarte and B. Silva-lima, Juvenile animal studies in the development of pediatric medicines: experience from European medicines and pediatric investigation plans, Birth Defects Research Part B: Developmental and Reproductive Toxicology, vol.58, 2011.
DOI : 10.1002/bdrb.20299

P. Dutta, R. Rasaily, M. R. Saha, U. Mitra, S. K. Bhattacharya et al., Ciprofloxacin for treatment of severe typhoid fever in children, Antimicrob Agents Chemother, issue.5, pp.37-1197, 1993.

K. Edmond and A. Zaidi, New Approaches to Preventing, Diagnosing, and Treating Neonatal Sepsis, PLoS Medicine, vol.354, issue.3, p.1000213, 2010.
DOI : 10.1371/journal.pmed.1000213.t002

M. Ehrnebo, S. Agurell, B. Jalling, and L. Boreus, Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults, European Journal of Clinical Pharmacology, vol.10, issue.Suppl. 403, pp.189-93, 1971.
DOI : 10.1007/BF00565004

S. Ekins-daukes, P. J. Helms, C. R. Simpson, M. W. Taylor, and J. S. Mclay, Off-label prescribing to children in primary care: retrospective observational study, European Journal of Clinical Pharmacology, vol.60, issue.5, pp.60-349, 2004.
DOI : 10.1007/s00228-004-0752-1

W. A. Engle, A Recommendation for the Definition of ???Late Preterm??? (Near-Term) and the Birth Weight???Gestational Age Classification System, Seminars in Perinatology, vol.30, issue.1, pp.2-7, 2006.
DOI : 10.1053/j.semperi.2006.01.007

E. I. Ette, Statistical Graphics in Pharmacokinetics and Pharmacodynamics: A Tutorial, Annals of Pharmacotherapy, vol.35, issue.7-8, pp.818-846, 1998.
DOI : 10.1345/aph.17304

B. I. Feinblatt, T. Aceto, . Jr, G. Beckhorn, and E. Bruck, Percutaneous Absorption of Hydrocortisone in Children, Archives of Pediatrics & Adolescent Medicine, vol.112, issue.3, pp.218-242, 1966.
DOI : 10.1001/archpedi.1966.02090120086008

J. Ferguson and B. Johnson, Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies, British Journal of Dermatology, vol.2, issue.1, pp.9-20, 1990.
DOI : 10.1111/1523-1747.ep12259992

A. Forrest, D. E. Nix, C. H. Ballow, T. F. Goss, M. C. Birmingham et al., Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients., Antimicrobial Agents and Chemotherapy, vol.37, issue.5, pp.37-1073, 1993.
DOI : 10.1128/AAC.37.5.1073

S. K. Fridkin, D. Kaufman, J. R. Edwards, S. Shetty, and T. Horan, Changing incidence of Candida bloodstream infections among NICU patients in the United States, Pediatrics, issue.5, pp.117-1680, 1995.

S. Friedman, S. E. Richardson, S. E. Jacobs, O. 'brien, and K. , Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome, The Pediatric Infectious Disease Journal, vol.19, issue.6, pp.19-499, 2000.
DOI : 10.1097/00006454-200006000-00002

J. Gaschignard, C. Levy, O. Romain, R. Cohen, E. Bingen et al., Neonatal Bacterial Meningitis, The Pediatric Infectious Disease Journal, vol.30, issue.3, pp.30-212, 2011.
DOI : 10.1097/INF.0b013e3181fab1e7

S. Gates, P. Brocklehurst, M. Campbell, and D. Elbourne, Recruitment to multicentre trials, BJOG: An International Journal of Obstetrics and Gynaecology, vol.318, issue.20, pp.3-5, 2004.
DOI : 10.1136/bmj.325.7355.81

V. Gavrilov, M. Lifshitz, J. Levy, and R. Gorodischer, Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel, Isr Med Assoc J, issue.28, pp.595-602, 2000.

D. Gendrel, M. Chalumeau, F. Moulin, R. , and J. , Fluoroquinolones in paediatrics: a risk for the patient or for the community?, The Lancet Infectious Diseases, vol.3, issue.9, pp.537-583, 2003.
DOI : 10.1016/S1473-3099(03)00736-9

G. Ghosh, S. Chakraborty, J. Ray, and S. K. Mukherjee, Parenteral ciprofloxacin in persistent diarrhoea in children, J Indian Med Assoc, issue.10, pp.93-382, 1995.

C. L. Gibert, M. Seiler, L. Joe, M. A. Smith, and F. Gordin, Intravenous and oral ciprofloxacin in the therapy of serious infections, Diagnostic Microbiology and Infectious Disease, vol.13, issue.2, pp.13-173, 1990.
DOI : 10.1016/0732-8893(90)90104-4

M. G. Gillan, S. Ross, F. J. Gilbert, A. M. Grant, O. Dwyer et al., Recruitment to multicentre trials: the impact of external influences, Health Bull, issue.3, pp.58-229, 2000.

G. Ginsberg, D. Hattis, R. Miller, and B. Sonawane, Pediatric pharmacokinetic data: implications for environmental risk assessment for children, Pediatrics, vol.113, issue.4, 2004.

P. Glasziou, J. P. Vandenbroucke, and I. Chalmers, Assessing the quality of research, BMJ, vol.328, issue.7430, pp.328-367, 2004.
DOI : 10.1136/bmj.328.7430.39

A. Gordon and D. Isaacs, Late-onset infection and the role of antibiotic prescribing policies, Current Opinion in Infectious Diseases, vol.17, issue.3
DOI : 10.1097/00001432-200406000-00010

A. Gordon and D. Isaacs, Late Onset Neonatal Gram-Negative Bacillary Infection in Australia and New Zealand, The Pediatric Infectious Disease Journal, vol.25, issue.1, pp.25-34, 2006.
DOI : 10.1097/01.inf.0000195628.35980.2e

A. Gordon and H. Jeffery, Antibiotic regimens for suspected late onset sepsis in newborn infants, Cochrane Database Syst Rev, issue.3, p.4501, 2005.

A. W. Gough, O. B. Kasali, R. E. Sigler, and V. Baragi, Quinolone arthropathy--acute toxicity to immature articular cartilage, Toxicol Pathol, vol.203, issue.1, pp.436-485, 1992.
DOI : 10.1177/019262339202000313

E. Guillot, I. Sermet, A. Ferroni, S. Chhun, G. Pons et al., Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis, Pharmacotherapy, issue.12, pp.30-1252, 2001.

A. Gurbay, B. Gonthier, L. Barret, A. Favier, and F. Hincal, Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by Vitamin E. Toxicology, pp.54-61, 2007.

A. Gurbay, B. Gonthier, N. Signorini-allibe, L. Barret, A. Favier et al., Ciprofloxacin-induced DNA damage in primary culture of rat astrocytes and protection by Vitamin E, NeuroToxicology, vol.27, issue.1, pp.27-33, 2006.
DOI : 10.1016/j.neuro.2005.05.007

B. Hampel, R. Hullmann, and H. Schmidt, Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report, The Pediatric Infectious Disease Journal, vol.16, issue.1, pp.127-136, 1997.
DOI : 10.1097/00006454-199701000-00036

S. C. Harth, R. R. Johnstone, and Y. H. Thong, The psychological profile of parents who volunteer their children for clinical research: a controlled study., Journal of Medical Ethics, vol.18, issue.2, pp.86-93, 1992.
DOI : 10.1136/jme.18.2.86

G. Hayem and C. Carbon, A Reappraisal of Quinolone Tolerability The Experience of their Musculoskeletal Adverse Effects, Drug Safety, vol.13, issue.6, pp.338-380, 1995.
DOI : 10.2165/00002018-199513060-00003

P. Hill, Off licence and off label prescribing in children: litigation fears for physicians, Archives of Disease in Childhood, vol.90, issue.suppl_1, pp.17-25, 2005.
DOI : 10.1136/adc.2004.058867

S. Hill, I. Regondi, M. Grzemska, and R. Matiru, Children and tuberculosis medicines: bridging the research gap, Bulletin of the World Health Organization, vol.86, issue.9, pp.86-658, 2008.
DOI : 10.2471/BLT.08.056804

R. N. Hines, The ontogeny of drug metabolism enzymes and implications for adverse drug events, Pharmacology & Therapeutics, vol.118, issue.2, pp.250-67, 2008.
DOI : 10.1016/j.pharmthera.2008.02.005

K. S. Hoehn, G. Wernovsky, J. Rychik, Z. Y. Tian, D. Donaghue et al., Parental decision-making in congenital heart disease, Cardiology in the Young, vol.14, issue.3, pp.14-309, 2004.
DOI : 10.1017/S1047951104003099

N. H. Holford and L. Sheiner, Understanding the Dose-Effect Relationship, Clinical Pharmacokinetics, vol.6, issue.6, pp.429-53, 1981.
DOI : 10.2165/00003088-198106060-00002

K. Hoppu, Paediatric clinical pharmacology???at the beginning of a new era, European Journal of Clinical Pharmacology, vol.9, issue.4, pp.201-206, 2008.
DOI : 10.1007/s00228-007-0390-5

K. Hoppu, Can we get the necessary clinical trials in children and avoid the unnecessary ones?, European Journal of Clinical Pharmacology, vol.86, issue.9, pp.65-747, 2009.
DOI : 10.1007/s00228-009-0675-y

K. Hoppu, G. Anabwani, F. Garcia-bournissen, M. Gazarian, G. L. Kearns et al., The status of paediatric medicines initiatives around the world???what has happened and what has not?, European Journal of Clinical Pharmacology, vol.20, issue.15, 2011.
DOI : 10.1007/s00228-011-1089-1

R. I. Horwitz, C. M. Viscoli, J. D. Clemens, and R. T. Sadock, Developing improved observational methods for evaluating therapeutic effectiveness, The American Journal of Medicine, vol.89, issue.5, pp.89-630, 1990.
DOI : 10.1016/0002-9343(90)90182-D

P. E. Hyman, D. D. Clarke, S. L. Everett, B. Sonne, D. Stewart et al., Gastric acid secretory function in preterm infants, The Journal of Pediatrics, vol.106, issue.3, pp.467-71, 1985.
DOI : 10.1016/S0022-3476(85)80682-X

I. Ince, S. N. De-wildt, D. Tibboel, M. Danhof, and C. A. Knibbe, Tailor-made drug treatment for children, Drug Discovery Today, vol.14, issue.5-6, pp.5-6, 2009.
DOI : 10.1016/j.drudis.2008.11.004

R. D. Inman, M. E. Johnston, M. Hodge, J. Falk, and A. Helewa, Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis, Arthritis Rheum, issue.11, pp.31-1377, 1988.

S. Jick, Ciprofloxacin safety in a pediatric population, The Pediatric Infectious Disease Journal, vol.16, issue.1, pp.130-133, 1997.
DOI : 10.1097/00006454-199701000-00037

T. N. Johnson, Modelling approaches to dose estimation in children, British Journal of Clinical Pharmacology, vol.55, issue.6, pp.663-672, 2005.
DOI : 10.1046/j.1365-2125.2003.01881.x

S. C. Johnston, T. Henneman, C. E. Mcculloch, and M. Van-der-laan, Modeling Treatment Effects on Binary Outcomes with Grouped-Treatment Variables and Individual Covariates, American Journal of Epidemiology, vol.156, issue.8
DOI : 10.1093/aje/kwf095

S. G. Joshi, V. S. Ghole, and K. B. Niphadkar, Neonatal gram-negative bacteremia, The Indian Journal of Pediatrics, vol.24, issue.2, pp.27-32, 2000.
DOI : 10.1007/BF02802632

S. Karande and N. A. Kshirsagar, Ciprofloxacin use: acute arthropathy and long-term follow up, Indian Pediatr, issue.11, pp.33-910, 1996.

M. G. Karlowicz, E. S. Buescher, and A. E. Surka, Fulminant Late-Onset Sepsis in a Neonatal Intensive Care Unit, 1988-1997, and the Impact of Avoiding Empiric Vancomycin Therapy, PEDIATRICS, vol.106, issue.6, pp.106-1387, 2000.
DOI : 10.1542/peds.106.6.1387

M. O. Karlsson and R. M. Savic, Diagnosing Model Diagnostics, Clinical Pharmacology & Therapeutics, vol.23, issue.1, pp.17-20, 2007.
DOI : 10.1038/sj.clpt.6100241

Y. Kashida and M. Kato, Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of antiinflammatory compounds, Antimicrob Agents Chemother, issue.11, pp.41-2389, 1997.

D. Kaufman, Neonatal Candidiasis: Clinical Manifestations, Management, and??Prevention Strategies, The Journal of Pediatrics, vol.156, issue.4, pp.47-52, 2010.
DOI : 10.1016/j.jpeds.2009.11.074

D. Kaufman and K. D. Fairchild, Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants, Clinical Microbiology Reviews, vol.17, issue.3, pp.638-80, 2004.
DOI : 10.1128/CMR.17.3.638-680.2004

D. A. Kaufman, Challenging issues in neonatal candidiasis, Current Medical Research and Opinion, vol.26, issue.7, pp.1769-78, 2010.
DOI : 10.1185/03007995.2010.487799

G. L. Kearns, S. M. Abdel-rahman, S. W. Alander, D. L. Blowey, J. S. Leeder et al., Developmental pharmacology--drug disposition, action, and therapy in infants and children, N Engl J Med, issue.12, pp.349-1157, 2003.

G. L. Kearns, P. K. Robinson, J. T. Wilson, D. Wilson-costello, G. R. Knight et al., Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny, Clinical Pharmacology & Therapeutics, vol.74, issue.4, pp.74-312, 2003.
DOI : 10.1016/S0009-9236(03)00225-X

J. A. Kellogg, F. L. Ferrentino, M. H. Goodstein, J. Liss, S. L. Shapiro et al., Frequency of low level bacteremia in infants from birth to two months of age, The Pediatric Infectious Disease Journal, vol.16, issue.4, pp.381-386, 1997.
DOI : 10.1097/00006454-199704000-00009

Y. Khaliq and G. G. Zhanel, Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature, Clinical Infectious Diseases, vol.36, issue.11, pp.36-1404, 2003.
DOI : 10.1086/375078

G. Klecak, F. Urbach, and H. Urwyler, Fluoroquinolone antibacterials enhance UVA-induced skin tumors, Journal of Photochemistry and Photobiology B: Biology, vol.37, issue.3, pp.174-81, 1997.
DOI : 10.1016/S1011-1344(96)07424-6

S. B. Koukouritaki, J. R. Manro, S. A. Marsh, J. C. Stevens, A. E. Rettie et al., Developmental Expression of Human Hepatic CYP2C9 and CYP2C19, Journal of Pharmacology and Experimental Therapeutics, vol.308, issue.3, pp.308-965, 2004.
DOI : 10.1124/jpet.103.060137

M. A. Koyle, A. Barqawi, J. Wild, M. Passamaneck, and P. D. Furness, Pediatric urinary tract infections: the role of fluoroquinolones, The Pediatric Infectious Disease Journal, vol.22, issue.12, pp.22-1133, 2003.
DOI : 10.1097/01.inf.0000101849.11912.8e

R. Kubin, Sicherheit und Wirksamkeit von Ciprofloxacin bei p??diatrischen Patienten ??? Eine Durchsicht der Literatur, Infection, vol.36, issue.Suppl. 5, pp.413-434, 1993.
DOI : 10.1007/BF01728929

P. Kumar, J. K. Walker, K. M. Hurt, K. M. Bennett, N. Grosshans et al., Medication Use in the Neonatal Intensive Care Unit: Current Patterns and Off-Label Use of Parenteral Medications, The Journal of Pediatrics, vol.152, issue.3, pp.152-412, 2008.
DOI : 10.1016/j.jpeds.2007.07.050

D. Lacroix, M. Sonnier, A. Moncion, G. Cheron, and T. Cresteil, Expression of CYP3A in the Human Liver - Evidence that the Shift between CYP3A7 and CYP3A4 Occurs Immediately After Birth, European Journal of Biochemistry, vol.34, issue.2, pp.247-625, 1997.
DOI : 10.1006/bbrc.1993.1803

J. D. Lantos, The ???inclusion benefit??? in clinical trials, The Journal of Pediatrics, vol.134, issue.2, pp.130-131, 1999.
DOI : 10.1016/S0022-3476(99)70400-2

B. Larroque, P. Y. Ancel, S. Marret, L. Marchand, M. Andre et al., Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study, The Lancet, vol.371, issue.9615, pp.371-813, 2008.
DOI : 10.1016/S0140-6736(08)60380-3

J. Lass, R. Kaar, K. Jogi, H. Varendi, T. Metsvaht et al., Drug utilisation pattern and off-label use of medicines in Estonian neonatal units, European Journal of Clinical Pharmacology, vol.99, issue.12, 2011.
DOI : 10.1007/s00228-011-1072-x

J. E. Lawn, S. Cousens, and J. Zupan, 4 million neonatal deaths: when? Where? Why? Lancet, pp.365-891, 2005.
DOI : 10.1016/s0140-6736(05)71048-5

J. E. Lawn, K. Wilczynska-ketende, and S. N. Cousens, Estimating the causes of 4 million neonatal deaths in the year 2000, International Journal of Epidemiology, vol.35, issue.3, pp.35-706, 2006.
DOI : 10.1093/ije/dyl043

L. Guellec, C. Autret-leca, E. Odoul, F. , J. Bera et al., Pharmacokinetic studies in neonatology: regulatory and methodologic problems

B. E. Lee, P. Y. Cheung, J. L. Robinson, C. Evanochko, and C. M. Robertson, Comparative Study of Mortality and Morbidity in Premature Infants (Birth Weight, <1,250 g) with Candidemia or Candidal Meningitis, Clinical Infectious Diseases, vol.27, issue.3, pp.27-559, 1998.
DOI : 10.1086/514712

H. Lee, D. S. Yim, H. Zhou, and C. C. Peck, Evidence of effectiveness: How much can we extrapolate from existing studies?, The AAPS Journal, vol.7, issue.2, pp.467-74, 2005.
DOI : 10.1208/aapsj070247

B. Lehmann, Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations, Child and Adolescent Psychiatry and Mental Health, vol.2, issue.1, p.37, 1901.
DOI : 10.1186/1753-2000-2-37

E. Leibovitz, O. Flidel-rimon, A. Juster-reicher, M. Amitay, A. Miskin et al., Sepsis at a neonatal intensive care unit: a four-year retrospective study, Isr J Med Sci, issue.11, pp.33-734, 1989.

E. Leibovitz, J. Janco, L. Piglansky, J. Press, P. Yagupsky et al., Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children, The Pediatric Infectious Disease Journal, vol.19, issue.11, pp.19-1060, 2000.
DOI : 10.1097/00006454-200011000-00006

W. Lenz, EPIDEMIOLOGY OF CONGENITAL MALFORMATIONS, Annals of the New York Academy of Sciences, vol.37, issue.5, pp.228-264, 1965.
DOI : 10.1111/j.1749-6632.1965.tb12261.x

R. Leone, M. Venegoni, D. Motola, U. Moretti, V. Piazzetta et al., Adverse Drug Reactions Related to the Use of Fluoroquinolone Antimicrobials, Drug Safety, vol.57, issue.6, pp.109-129, 2003.
DOI : 10.2165/00002018-200326020-00004

M. Levene, I. Wright, and G. Griffiths, Is informed consent in neonatal randomised controlled trials ritual? Lancet, pp.347-475, 1996.

O. Levy, Innate immunity of the newborn: basic mechanisms and clinical correlates, Nature Reviews Immunology, vol.21, issue.5, pp.379-90, 2007.
DOI : 10.1038/nri2075

P. Li, N. N. Cheng, B. Y. Chen, and Y. M. Wang, In vivo and in vitro chondrotoxicity of ciprofloxacin in juvenile rats, Acta Pharmacol Sin, issue.10, pp.25-1262, 2004.

L. Lindbom, P. Pihlgren, and E. N. Jonsson, PsN-Toolkit???A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM, Computer Methods and Programs in Biomedicine, vol.79, issue.3, pp.79-241, 2005.
DOI : 10.1016/j.cmpb.2005.04.005

L. Lindell-osuagwu, M. J. Korhonen, S. Saano, M. Helin-tanninen, T. Naaranlahti et al., Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature, Journal of Clinical Pharmacy and Therapeutics, vol.161, issue.3, pp.34-277, 2009.
DOI : 10.1111/j.1365-2710.2008.01005.x

D. A. Linseman, L. A. Hampton, and D. G. Branstetter, Quinolone-Induced Arthropathy in the Neonatal Mouse: Morphological Analysis of Articular Lesions Produced by Pipemidic Acid and Ciprofloxacin, Fundamental and Applied Toxicology, vol.28, issue.1, pp.59-64, 1995.
DOI : 10.1006/faat.1995.1146

B. A. Lipsky and C. A. Baker, Fluoroquinolone Toxicity Profiles: A Review Focusing on Newer Agents, Clinical Infectious Diseases, vol.28, issue.2, pp.352-64, 1999.
DOI : 10.1086/515104

L. Martinez, R. , C. Poy, M. J. Oliveras-arenas, M. et al., Utilizaci??n de medicamentos en una UCI neonatal: estudio prospectivo, Farmacia Hospitalaria, vol.29, issue.1, pp.26-35, 2005.
DOI : 10.1016/S1130-6343(05)73632-1

J. Lumley, A. Lester, P. Renou, and C. Wood, A failed RCT to determine the best method of delivery for very low birth weight infants, Controlled Clinical Trials, vol.6, issue.2, pp.120-127, 1985.
DOI : 10.1016/0197-2456(85)90117-5

M. Machida, H. Kusajima, H. Aijima, A. Maeda, R. Ishida et al., Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals, Toxicology and Applied Pharmacology, vol.105, issue.3, pp.105-403, 1990.
DOI : 10.1016/0041-008X(90)90144-J

K. Maebashi, M. Niimi, M. Kudoh, F. J. Fischer, K. Makimura et al., Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients, Journal of Antimicrobial Chemotherapy, vol.47, issue.5, pp.47-527, 2001.
DOI : 10.1093/jac/47.5.527

E. Manolis, T. E. Osman, R. Herold, F. Koenig, P. Tomasi et al., Role of modeling and simulation in pediatric investigation plans, Pediatric Anesthesia, vol.284, issue.3, pp.214-235, 2011.
DOI : 10.1111/j.1460-9592.2011.03523.x

E. Manolis and G. Pons, Proposals for model-based paediatric medicinal development within the current European Union regulatory framework, British Journal of Clinical Pharmacology, vol.34, issue.4, pp.493-501, 2009.
DOI : 10.1111/j.1365-2125.2009.03484.x

P. Manzoni, M. Leonessa, P. Galletto, M. A. Latino, R. Arisio et al., Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazoleresistant Candida subspecies, Pediatr Infect Dis J, issue.8, pp.27-731, 2008.

J. Mapstone, D. Elbourne, and I. Roberts, Strategies to improve recruitment to research studies, Cochrane Database Syst Rev, issue.2, p.13, 2007.

F. Marchetti, J. Bua, A. Ventura, L. D. Notarangelo, D. Maio et al., The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals, European Journal of Clinical Pharmacology, vol.91, issue.9164, pp.81-86, 2007.
DOI : 10.1007/s00228-006-0223-y

L. Marodi, Neonatal Innate Immunity to Infectious Agents, Infection and Immunity, vol.74, issue.4, pp.1999-2006, 2006.
DOI : 10.1128/IAI.74.4.1999-2006.2006
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1418902

S. Mason, Obtaining informed consent for neonatal randomised controlled trials--an "elaborate ritual"? Arch Dis Child Fetal Neonatal Ed, pp.76-143, 1997.

S. A. Mason and P. J. Allmark, Obtaining informed consent to neonatal randomised controlled trials: interviews with parents and clinicians in the Euricon study, The Lancet, vol.356, issue.9247, pp.356-2045, 2000.
DOI : 10.1016/S0140-6736(00)03401-2

D. G. Mccarver and R. N. Hines, The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms, Journal of Pharmacology and Experimental Therapeutics, vol.300, issue.2, pp.361-367, 2002.
DOI : 10.1124/jpet.300.2.361

J. Mcintyre, S. Conroy, and A. Avery, Corns, H. and Choonara, I. Unlicensed and off label prescribing of drugs in general practice, Arch Dis Child, issue.6, pp.83-498, 2000.

S. B. Meropol, K. A. Chan, Z. Chen, J. A. Finkelstein, S. Hennessy et al., Adverse events associated with prolonged antibiotic use, Pharmacoepidemiology and Drug Safety, vol.29, issue.5, pp.17-523, 2008.
DOI : 10.1002/pds.1547
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269235

N. Modi, Clinical trials and neonatal intensive care., Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.70, issue.3, pp.231-233, 1994.
DOI : 10.1136/fn.70.3.F231-a
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1061052

C. J. Morley, R. Lau, P. G. Davis, and C. Morse, What do parents think about enrolling their premature babies in several research studies? Arch Dis Child Fetal Neonatal Ed, pp.90-225, 2005.

J. W. Mouton, M. N. Dudley, O. Cars, H. Derendorf, and G. L. Drusano, Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update, Journal of Antimicrobial Chemotherapy, vol.55, issue.5, pp.55-601, 2005.
DOI : 10.1093/jac/dki079

E. I. Mtitimila and R. W. Cooke, Antibiotic regimens for suspected early neonatal sepsis, Cochrane Database Syst Rev, issue.4, p.4495, 2004.

M. Mueller, A. De-la-pena, and H. Derendorf, Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC, Antimicrobial Agents and Chemotherapy, vol.48, issue.2, pp.369-77, 2004.
DOI : 10.1128/AAC.48.2.369-377.2004

C. A. Mullen, Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients, The Pediatric Infectious Disease Journal, vol.22, issue.12, pp.22-1138, 2003.
DOI : 10.1097/01.inf.0000101993.83884.ed

C. A. Mullen, D. Petropoulos, W. M. Roberts, M. Rytting, T. Zipf et al., Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients, Cancer, vol.128, issue.1, pp.126-160, 1999.
DOI : 10.1002/(SICI)1097-0142(19990701)86:1<126::AID-CNCR18>3.0.CO;2-1

A. Nagai, M. Miyazaki, T. Morita, S. Furubo, K. Kizawa et al., Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs., The Journal of Toxicological Sciences, vol.27, issue.3, pp.27-219, 2002.
DOI : 10.2131/jts.27.219

S. Nambiar and N. Singh, Change in epidemiology of health care-associated infections in a neonatal intensive care unit, The Pediatric Infectious Disease Journal, vol.21, issue.9, pp.839-881, 2002.
DOI : 10.1097/00006454-200209000-00011

A. Neubert, K. Lukas, T. Leis, H. Dormann, K. Brune et al., Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis, European Journal of Clinical Pharmacology, vol.148, issue.1, pp.66-87, 2010.
DOI : 10.1007/s00228-009-0722-8
URL : https://hal.archives-ouvertes.fr/hal-00534992

A. Neubert, I. C. Wong, A. Bonifazi, M. Catapano, M. Felisi et al., Defining off-label and unlicensed use of medicines for children: Results of a Delphi survey, Pharmacological Research, vol.58, issue.5-6, pp.5-6, 2008.
DOI : 10.1016/j.phrs.2008.09.007

S. Nicklin and S. A. Spencer, Recruitment failure in early neonatal research, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.89, issue.3, p.281, 2004.
DOI : 10.1136/adc.2003.043711

M. G. Rinaldi, J. L. Rodriguez-tudela, W. A. Schell, C. Shields, D. A. Sutton et al., Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species, J Clin Microbiol, issue.8, pp.42-3475, 2004.

O. Donnell, C. P. Stone, R. J. Morley, and C. J. , Unlicensed and off-label drug use in an Australian neonatal intensive care unit, Pediatrics, issue.5, pp.110-52, 2002.

L. Ohman, K. Tullus, M. Katouli, L. G. Burman, and O. Stendahl, Correlation Between Susceptibility Of Infants To Infections And Interaction With Neutrophils Of Escherichia Coli Strains Causing Neonatal And Infantile Septicemia, Journal of Infectious Diseases, vol.171, issue.1, pp.171-128, 1995.
DOI : 10.1093/infdis/171.1.128

T. M. Olski, S. F. Lampus, G. Gherarducci, S. Raymond, and A. , Three years of paediatric regulation in the European Union, European Journal of Clinical Pharmacology, vol.3, issue.S2, pp.67-245, 2011.
DOI : 10.1007/s00228-011-0997-4

R. C. Owens, . Jr, and P. G. Ambrose, CLINICAL USE OF THE FLUOROQUINOLONES, Medical Clinics of North America, vol.84, issue.6, pp.1447-69, 2000.
DOI : 10.1016/S0025-7125(05)70297-2

H. Paganini, S. Gomez, S. Ruvinsky, P. Zubizarreta, A. Latella et al., Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease, Cancer, vol.30, issue.7, pp.97-1775, 2003.
DOI : 10.1002/cncr.11251

H. Paganini, T. Rodriguez-brieshcke, P. Zubizarreta, A. Latella, V. Firpo et al., Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia, Cancer, vol.14, issue.8, pp.91-1563, 2001.
DOI : 10.1002/1097-0142(20010415)91:8<1563::AID-CNCR1166>3.0.CO;2-C

C. Pandolfini and M. Bonati, A literature review on off-label drug use in children, European Journal of Pediatrics, vol.8, issue.9, pp.552-560, 2005.
DOI : 10.1007/s00431-005-1698-8

P. G. Pappas, J. H. Rex, J. Lee, R. J. Hamill, R. A. Larsen et al., A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients, Clinical Infectious Diseases, vol.37, issue.5, pp.37-634, 2003.
DOI : 10.1086/376906

A. Pariente-khayat, F. Vauzelle-kervroedan, P. Athis, G. Breart, D. Gendrel et al., Retrospective survey of fluoroquinolone use in children], Arch Pediatr, issue.55, pp.484-492, 1998.

S. Payen, R. Serreau, A. Munck, Y. Aujard, Y. Aigrain et al., Population Pharmacokinetics of Ciprofloxacin in Pediatric and Adolescent Patients with Acute Infections, Antimicrobial Agents and Chemotherapy, vol.47, issue.10, pp.47-3170, 2003.
DOI : 10.1128/AAC.47.10.3170-3178.2003

C. C. Peck, D. B. Rubin, and L. B. Sheiner, Hypothesis: A single clinical trial plus causal evidence of effectiveness is sufficient for drug approval, Clinical Pharmacology & Therapeutics, vol.73, issue.6, pp.73-481, 2003.
DOI : 10.1016/S0009-9236(03)00018-3

H. Peltola, P. Ukkonen, H. Saxen, and H. Stass, Single-dose and Steady-state Pharmacokinetics of a New Oral Suspension of Ciprofloxacin in Children, PEDIATRICS, vol.101, issue.4, pp.658-62, 1998.
DOI : 10.1542/peds.101.4.658

E. Pertuiset, G. Lenoir, M. Jehanne, F. Douchain, M. Guillot et al., Joint tolerance of pefloxacin and ofloxacin in children and adolescents with cystic fibrosis

A. S. Petrilli, L. S. Dantas, M. C. Campos, C. Tanaka, V. C. Ginani et al., Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial

K. Pfister, D. Mazur, J. Vormann, and R. Stahlmann, Diminished Ciprofloxacin-Induced Chondrotoxicity by Supplementation with Magnesium and Vitamin E in Immature Rats, Antimicrobial Agents and Chemotherapy, vol.51, issue.3
DOI : 10.1128/AAC.01175-06

A. Pong and J. S. Bradley, BACTERIAL MENINGITIS AND THE NEWBORN INFANT, Infectious Disease Clinics of North America, vol.13, issue.3, pp.711-744, 1999.
DOI : 10.1016/S0891-5520(05)70102-1

A. Porta, S. Esposito, E. Menson, N. Spyridis, M. Tsolia et al., Off-label antibiotic use in children in three European countries, European Journal of Clinical Pharmacology, vol.1, issue.Suppl. 2, pp.66-919, 2010.
DOI : 10.1007/s00228-010-0842-1
URL : https://hal.archives-ouvertes.fr/hal-00598942

T. M. Post, J. I. Freijer, B. A. Ploeger, and M. Danhof, Extensions to the Visual Predictive Check to facilitate model performance evaluation, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.5, pp.185-202, 2008.
DOI : 10.1007/s10928-007-9081-1

V. Rahm and P. Schacht, Safety of ciprofloxacin. A review, Scand J Infect Dis, vol.60, pp.120-128, 1989.

S. Rahman, A. Hameed, M. T. Roghani, and Z. Ullah, Multidrug resistant neonatal sepsis in Peshawar, Pakistan, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.87, issue.1, pp.52-56, 2002.
DOI : 10.1136/fn.87.1.F52

P. Rajagopalan and M. R. Gastonguay, Population Pharmacokinetics of Ciprofloxacin in Pediatric Patients, The Journal of Clinical Pharmacology, vol.14, issue.7, pp.43-698, 2003.
DOI : 10.1177/0091270003254802

J. M. Rendell, R. D. Merritt, and J. Geddes, Incentives and disincentives to participation by clinicians in randomised controlled trials, Cochrane Database Syst Rev, issue.2, p.2007

J. H. Rex, M. G. Rinaldi, and M. A. Pfaller, Resistance of Candida species to fluconazole, Antimicrobial Agents and Chemotherapy, vol.39, issue.1, pp.1-8, 1995.
DOI : 10.1128/AAC.39.1.1

D. Rice, S. Barone, and . Jr, Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models, Environ Health Perspect, p.108, 2000.

D. A. Richard, S. Nousia-arvanitakis, V. Sollich, B. J. Hampel, B. Sommerauer et al., Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging, The Pediatric Infectious Disease Journal, vol.16, issue.6
DOI : 10.1097/00006454-199706000-00007

J. A. Roberts and J. Lipman, Antibacterial Dosing in Intensive Care, Clinical Pharmacokinetics, vol.11, issue.2, pp.45-755, 2006.
DOI : 10.2165/00003088-200645080-00001

R. Roberts, W. Rodriguez, D. Murphy, and T. Crescenzi, Pediatric Drug Labeling, JAMA, vol.290, issue.7, pp.290-905, 2003.
DOI : 10.1001/jama.290.7.905

J. Robillard, E. Guillery, and J. Petershack, Renal function during fetal life Pediatric nephrology 4th, 1999.

F. Rocchi and P. Tomasi, The development of medicines for children, Pharmacological Research, vol.64, issue.3, pp.169-75, 2011.
DOI : 10.1016/j.phrs.2011.01.016

T. T. Rubio, Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis, Diagnostic Microbiology and Infectious Disease, vol.13, issue.2, pp.153-158, 1990.
DOI : 10.1016/0732-8893(90)90099-H

T. T. Rubio, M. V. Miles, J. T. Lettieri, R. J. Kuhn, R. M. Echols et al., Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation, The Pediatric Infectious Disease Journal, vol.16, issue.1, pp.112-119, 1997.
DOI : 10.1097/00006454-199701000-00033

M. A. Salam, U. Dhar, W. A. Khan, and M. L. Bennish, Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis, The Lancet, vol.352, issue.9127, pp.352-522, 1998.
DOI : 10.1016/S0140-6736(97)11457-X

E. Sarvikivi, O. Lyytikainen, D. R. Soll, C. Pujol, M. A. Pfaller et al., Emergence of Fluconazole Resistance in a Candida parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit, Journal of Clinical Microbiology, vol.43, issue.6, pp.43-2729, 2005.
DOI : 10.1128/JCM.43.6.2729-2735.2005

U. B. Schaad, Fluoroquinolone Antibiotics in Infants and Children, Infectious Disease Clinics of North America, vol.19, issue.3, pp.617-645, 2005.
DOI : 10.1016/j.idc.2005.05.005

P. Schacht, G. Arcieri, and R. Hullmann, Safety of oral ciprofloxacin, The American Journal of Medicine, vol.87, issue.5, pp.98-102, 1989.
DOI : 10.1016/0002-9343(89)90033-8

H. G. Schaefer, H. Stass, J. Wedgwood, B. Hampel, C. Fischer et al., Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients, Antimicrob Agents Chemother, issue.1, pp.40-69, 1996.

R. L. Schelonka, M. K. Chai, B. A. Yoder, D. Hensley, R. M. Brockett et al., Volume of blood required to detect common neonatal pathogens, The Journal of Pediatrics, vol.129, issue.2, pp.129-275, 1996.
DOI : 10.1016/S0022-3476(96)70254-8

B. Schmidt, P. Gillie, C. Caco, J. Roberts, and R. Roberts, Do sick newborn infants benefit from participation in a randomized clinical trial?, The Journal of Pediatrics, vol.134, issue.2, pp.151-156, 1999.
DOI : 10.1016/S0022-3476(99)70428-2

B. Schmidt, R. S. Roberts, P. Davis, L. W. Doyle, K. J. Barrington et al., Long-Term Effects of Caffeine Therapy for Apnea of Prematurity, New England Journal of Medicine, vol.357, issue.19, pp.357-1893, 2007.
DOI : 10.1056/NEJMoa073679

B. Schmidt, P. J. Anderson, L. W. Doyle, D. Dewey, R. E. Grunau et al., Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity, JAMA, vol.307, issue.3, pp.307-275, 2012.
DOI : 10.1001/jama.2011.2024

C. Schmoor, A. Caputo, and M. Schumacher, Evidence from Nonrandomized Studies: A Case Study on the Estimation of Causal Effects, American Journal of Epidemiology, vol.167, issue.9, pp.1120-1129, 2008.
DOI : 10.1093/aje/kwn010

S. Sen, R. S. Goyal, and R. Dev, Ciprofloxacin in the management of multiple drug resistant typhoid fever, Indian Pediatr, vol.28, issue.4, pp.417-426, 1991.

R. E. Shaddy and S. C. Denne, Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations, PEDIATRICS, vol.125, issue.4, pp.850-60, 2010.
DOI : 10.1542/peds.2010-0082

S. S. Shah, R. A. Ehrenkranz, and P. G. Gallagher, Increasing incidence of Gram-negative rod bacteremia in a newborn intensive care unit, The Pediatric Infectious Disease Journal, vol.18, issue.7, pp.18-591, 1999.
DOI : 10.1097/00006454-199907000-00005

S. S. Shah, M. Hall, D. M. Goodman, P. Feuer, V. Sharma et al., Offlabel drug use in hospitalized children, Arch Pediatr Adolesc Med, issue.3, pp.161-282, 2007.

P. C. Sharma, A. Jain, S. Jain, R. Pahwa, and M. S. Yar, Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects, Journal of Enzyme Inhibition and Medicinal Chemistry, vol.34, issue.4, pp.577-89, 2010.
DOI : 10.1128/AAC.44.10.2600-2603.2000

V. Shilling, P. R. Williamson, H. Hickey, E. Sowden, M. W. Beresford et al., Communication about Children's Clinical Trials as Observed and Experienced: Qualitative Study of Parents and Practitioners, PLoS ONE, vol.123, issue.7, p.21604, 2010.
DOI : 10.1371/journal.pone.0021604.s005

B. Silva-lima, M. Due-theilade-thomsen, J. Carleer, J. M. Vidal, P. Tomasi et al., Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European medicines agency workshop on juvenile animal testing for nonclinical assessors, Birth Defects Research Part B: Developmental and Reproductive Toxicology, vol.68, issue.6, pp.89-467, 2010.
DOI : 10.1002/bdrb.20257

N. Singhal, K. Oberle, E. Burgess, and J. Huber-okrainec, Parents' Perceptions of Research With Newborns, Journal of Perinatology, vol.22, issue.1, pp.57-63, 2002.
DOI : 10.1038/sj.jp.7210608

N. Singhal, K. Oberle, A. Darwish, and E. Burgess, Attitudes of Health-Care Providers towards Research with Newborn Babies, Journal of Perinatology, vol.24, issue.12, pp.24-775, 2004.
DOI : 10.1038/sj.jp.7211171

R. L. Smyth and A. M. Weindling, Research in children: ethical and scientific aspects, The Lancet, vol.354, issue.2, pp.21-25, 1999.
DOI : 10.1016/S0140-6736(99)90253-2

C. Snowdon, D. Elbourne, and J. Garcia, Zelen randomization: Attitudes of parents participating in a neonatal clinical trial, Controlled Clinical Trials, vol.19, issue.3, pp.149-71, 1999.
DOI : 10.1016/S0197-2456(98)80183-9

C. Snowdon, J. Garcia, and D. Elbourne, Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial, Social Science & Medicine, vol.45, issue.9, pp.45-1337, 1997.
DOI : 10.1016/S0277-9536(97)00063-4

M. Sonnier and T. Cresteil, Delayed ontogenesis of CYP1A2 in the human liver, European Journal of Biochemistry, vol.251, issue.3, pp.893-901, 1998.
DOI : 10.1046/j.1432-1327.1998.2510893.x

A. Stark, Levels of neonatal care, Pediatrics, vol.114, issue.5, pp.1341-1348, 2004.

R. Steinbrook, Testing Medications in Children, New England Journal of Medicine, vol.347, issue.18, pp.1462-70, 2002.
DOI : 10.1056/NEJMhpr021646

B. J. Stenson, J. C. Becher, and N. Mcintosh, Neonatal research: the parental perspective, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.89, issue.4, pp.321-324, 2004.
DOI : 10.1136/adc.2002.021931

T. Stephenson, How children's responses to drugs differ from adults, British Journal of Clinical Pharmacology, vol.101, issue.6, pp.670-673, 2005.
DOI : 10.1677/joe.1.05732

B. J. Stoll, T. Gordon, S. B. Korones, S. Shankaran, J. E. Tyson et al., Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network, The Journal of Pediatrics, vol.129, issue.1, pp.72-80, 1996.
DOI : 10.1016/S0022-3476(96)70192-0

B. J. Stoll, T. Gordon, S. B. Korones, S. Shankaran, J. E. Tyson et al., Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network, The Journal of Pediatrics, vol.129, issue.1, pp.63-71, 1996.
DOI : 10.1016/S0022-3476(96)70191-9

B. J. Stoll, N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo et al., Lateonset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network, Pediatrics, issue.2, pp.110-285, 2002.

B. J. Stoll, N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo et al., Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants, New England Journal of Medicine, vol.347, issue.4, pp.240-247, 2002.
DOI : 10.1056/NEJMoa012657

B. J. Stoll, N. I. Hansen, I. Adams-chapman, A. A. Fanaroff, S. R. Hintz et al., Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection, Jama, pp.292-2357, 2004.

B. J. Stoll, N. I. Hansen, R. D. Higgins, A. A. Fanaroff, S. Duara et al., Very Low Birth Weight Preterm Infants With Early Onset Neonatal Sepsis, The Pediatric Infectious Disease Journal, vol.24, issue.7, pp.24-635, 2002.
DOI : 10.1097/01.inf.0000168749.82105.64

S. Benedetti, M. Baltes, and E. L. , Drug metabolism and disposition in children, Fundamental & Clinical Pharmacology, vol.25, issue.3, pp.281-99, 2003.
DOI : 10.1046/j.1472-8206.2003.00140.x

M. C. Sturkenboom, K. M. Verhamme, A. Nicolosi, M. L. Murray, A. Neubert et al., Drug use in children: cohort study in three European countries, BMJ, vol.337, issue.nov24 2, p.2245, 2008.
DOI : 10.1136/bmj.a2245

G. W. Jong, P. D. Van-der-linden, E. M. Bakker, N. Van-der-lely, I. A. Eland et al., Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands, European Journal of Clinical Pharmacology, vol.58, issue.4, pp.293-300, 2002.
DOI : 10.1007/s00228-002-0479-9

G. W. Jong, A. G. Vulto, M. De-hoog, K. J. Schimmel, D. Tibboel et al., A Survey of the Use of Off-Label and Unlicensed Drugs in a Dutch Children's Hospital, PEDIATRICS, vol.108, issue.5, pp.1089-93, 2001.
DOI : 10.1542/peds.108.5.1089

G. Tafuri, F. Trotta, H. G. Leufkens, N. Martini, L. Sagliocca et al., Off-label use of medicines in children: can available evidence avoid useless paediatric trials?, European Journal of Clinical Pharmacology, vol.150, issue.Suppl 4, pp.65-209, 2009.
DOI : 10.1007/s00228-008-0560-0
URL : https://hal.archives-ouvertes.fr/hal-00477924

A. R. Tait, T. Voepel-lewis, and S. Malviya, Participation of Children in Clinical Research, Anesthesiology, vol.99, issue.4, pp.819-844, 2003.
DOI : 10.1097/00000542-200310000-00012

D. Thaver and A. K. Zaidi, Burden of Neonatal Infections in Developing Countries, The Pediatric Infectious Disease Journal, vol.28, issue.Supplement, pp.3-9, 2009.
DOI : 10.1097/INF.0b013e3181958755

M. Tod, V. Jullien, and G. Pons, Facilitation of Drug Evaluation in Children by??Population Methods and Modelling???, Clinical Pharmacokinetics, vol.116, issue.4, pp.231-274, 2008.
DOI : 10.2165/00003088-200847040-00002

J. M. Treluyer, E. Jacqz-aigrain, F. Alvarez, and T. Cresteil, Expression of CYP2D6 in developing human liver, European Journal of Biochemistry, vol.239, issue.2, pp.583-591, 1991.
DOI : 10.1016/S0140-6736(77)91430-1

R. D. Truog, W. Robinson, A. Randolph, and A. Morris, Is informed consent always necessary for randomized, controlled trials?, N Engl J Med, issue.10, pp.340-804, 1999.

J. Tucker and W. Mcguire, Epidemiology of preterm birth, BMJ, vol.329, issue.7467, pp.675-683, 2004.
DOI : 10.1136/bmj.329.7467.675

S. Turner, A. J. Nunn, K. Fielding, and I. Choonara, Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study, Acta Paediatrica, vol.78, issue.9, pp.965-973, 1999.
DOI : 10.1111/j.1651-2227.1999.tb00191.x

J. N. Van-den-anker, R. De-groot, H. M. Broerse, P. J. Sauer, B. J. Van-der-heijden et al., Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance, Pediatrics, issue.6, pp.96-1156, 1995.

J. N. Van-den-anker, R. C. Schoemaker, W. C. Hop, B. J. Van-der-heijden, A. Weber et al., Ceftazidime pharmacokinetics in preterm infants: Effects of renal function and gestational age*, Clinical Pharmacology & Therapeutics, vol.329, issue.6, pp.58-650, 1995.
DOI : 10.1016/0009-9236(95)90021-7

P. D. Van-der-linden, M. C. Sturkenboom, R. M. Herings, H. G. Leufkens, and B. H. Stricker, Fluoroquinolones and risk of Achilles tendon disorders: case-control study, BMJ, vol.324, issue.7349, pp.324-1306, 2002.
DOI : 10.1136/bmj.324.7349.1306

P. D. Van-der-linden, J. Van-de-lei, H. W. Nab, A. Knol, and B. H. Stricker, Achilles tendinitis associated with fluoroquinolones, British Journal of Clinical Pharmacology, vol.143, issue.3, pp.48-433, 1999.
DOI : 10.1046/j.1365-2125.1999.00016.x

P. Van-reempts, L. Gortner, D. Milligan, M. Cuttini, S. Petrou et al., Characteristics of Neonatal Units That Care for Very Preterm Infants in Europe: Results From the MOSAIC Study, PEDIATRICS, vol.120, issue.4, pp.815-840, 2007.
DOI : 10.1542/peds.2006-3122

J. P. Vandenbroucke, When are observational studies as credible as randomised trials? Lancet, pp.1728-1759, 2004.
DOI : 10.1016/s0140-6736(04)16261-2

M. P. Venkatesh and J. A. Garcia-prats, Management of neonatal sepsis by Gram-negative pathogens, Expert Review of Anti-infective Therapy, vol.6, issue.6, pp.929-967, 2008.
DOI : 10.1586/14787210.6.6.929

I. Vieira, M. Sonnier, and T. Cresteil, Developmental Expression of CYP2E1 in the Human Liver. Hypermethylation Control of Gene Expression During the Neonatal Period, European Journal of Biochemistry, vol.7, issue.2, pp.476-83, 1996.
DOI : 10.1006/bbrc.1994.2777

E. Von-keutz, C. Ruhl-fehlert, W. Drommer, and M. Rosenbruch, Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period, Archives of Toxicology, vol.78, issue.7, pp.78-418, 2004.
DOI : 10.1007/s00204-004-0551-6

J. N. Walterspiel, Informed consent: influence on patient selection among critically ill premature infants, Pediatrics, vol.85, issue.1, pp.119-140, 1990.

J. Wang and P. Donnan, Propensity score methods in drug safety studies: practice, strengths and limitations, Pharmacoepidemiology and Drug Safety, vol.18, issue.4, pp.341-345, 2001.
DOI : 10.1002/pds.656

W. Platt and M. , Participation in multiple neonatal research studies, Arch Dis Child Fetal Neonatal Ed, issue.3, pp.90-191, 2005.

R. W. Warren, Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones, The Pediatric Infectious Disease Journal, vol.16, issue.1, pp.118-140, 1997.
DOI : 10.1097/00006454-199701000-00034

C. F. Weiss, A. J. Glazko, and J. K. Weston, Chloramphenicol in the Newborn Infant, New England Journal of Medicine, vol.262, issue.16, pp.787-94, 1960.
DOI : 10.1056/NEJM196004212621601

D. Wendler and T. Jenkins, Children's and Their Parents' Views on Facing Research Risks for the Benefit of Others, Archives of Pediatrics & Adolescent Medicine, vol.162, issue.1, pp.9-14, 2008.
DOI : 10.1001/archpediatrics.2007.3

J. M. Wiley, Fungal Infections in Pediatric Immunocompromised Patients: Epidemiology, Principles of Treatment, and Promising Antifungal Agents, The Journal of Pediatrics, vol.156, issue.4, pp.74-82, 2010.
DOI : 10.1016/j.jpeds.2009.11.075

C. B. Wilson, Immunologic basis for increased susceptibility of the neonate to infection, The Journal of Pediatrics, vol.108, issue.1, pp.1-12, 1986.
DOI : 10.1016/S0022-3476(86)80761-2

N. S. Wood, N. Marlow, K. Costeloe, A. T. Gibson, and A. R. Wilkinson, Neurologic and developmental disability after extremely preterm birth. EPICure Study Group, N Engl J Med, issue.6, pp.343-378, 2000.
DOI : 10.1097/00006254-200101000-00010

A. Yafune and M. Ishiguro, Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. II: a bootstrap modification of standard two-stage (STS) method for phase I trial, Statistics in Medicine, vol.10, issue.5, pp.601-613, 1999.
DOI : 10.1002/(SICI)1097-0258(19990315)18:5<601::AID-SIM48>3.0.CO;2-L

Y. Yano, S. L. Beal, and L. Sheiner, Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.2, pp.171-92, 2001.
DOI : 10.1023/A:1011555016423

C. L. Yee, C. Duffy, P. G. Gerbino, S. Stryker, and G. J. Noel, Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin, The Pediatric Infectious Disease Journal, vol.21, issue.6, pp.525-534, 2002.
DOI : 10.1097/00006454-200206000-00009

A. K. Zaidi, W. C. Huskins, D. Thaver, Z. A. Bhutta, Z. Abbas et al., Hospital-acquired neonatal infections in developing countries, The Lancet, vol.365, issue.9465, pp.365-1175, 2005.
DOI : 10.1016/S0140-6736(05)71881-X

A. K. Zaidi, D. Thaver, S. A. Ali, and T. A. Khan, Pathogens Associated With Sepsis in Newborns and Young Infants in Developing Countries, The Pediatric Infectious Disease Journal, vol.28, issue.Supplement, 2009.
DOI : 10.1097/INF.0b013e3181958769

T. E. Zaoutis, E. Foraker, K. L. Mcgowan, J. Mortensen, J. Campos et al., Antifungal susceptibility of Candida spp. isolated from pediatric patients: A survey of 4 children's hospitals, Diagnostic Microbiology and Infectious Disease, vol.52, issue.4, pp.295-303, 2005.
DOI : 10.1016/j.diagmicrobio.2005.03.002

J. Zeitlin, M. Ayoubi, P. H. Jarreau, E. S. Draper, B. Blondel et al., Impact of Fetal Growth Restriction on Mortality and Morbidity in a Very Preterm Birth Cohort, The Journal of Pediatrics, vol.157, issue.5, pp.157-733, 2010.
DOI : 10.1016/j.jpeds.2010.05.002

J. Zeitlin, E. Papiernik, and G. Breart, Regionalization of perinatal care in Europe, Seminars in Neonatology, vol.9, issue.2, pp.99-110, 2004.
DOI : 10.1016/j.siny.2003.08.004

J. A. Zupancic, P. Gillie, D. L. Streiner, J. L. Watts, and B. Schmidt, Determinants of Parental Authorization for Involvement of Newborn Infants in Clinical Trials, PEDIATRICS, vol.99, issue.1, pp.99-105, 1997.
DOI : 10.1542/peds.99.1.e6

E. Documents-réglementaires, Points to Consider on Pharmacokinetics and Pharmacodynamics in the Development of Antibacterial Medicinal Products, p.2655, 2000.

I. E11, Clinical Investigation of medicinal products in the paediatric population (CPMP/ICH/2711/99), 1999.